Nu Skin (NUS) Q4 Results in China Better than Feared; BTIG Maintains 'Neutral' Rating
BTIG maintains a Neutral stance on Nu Skin Enterprises (NYSE: NUS) following the company's Q4 results and Q1 outlook issued ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
